Fibrocell Prices 11 Mln. Share Offering At $4.10 Apiece

(RTTNews) - Fibrocell Science Inc. (FCSC), an autologous cell therapy company, said Thursday it has priced an underwritten public offering of 11 million of its common shares at $4.10 per share for aggregate gross proceeds of $45.1 million.

The company has granted the underwriters a 30-day option to purchase up to an additional 1.65 million shares to cover over-allotments.

The offering is expected to close on or about October 1, subject to customary closing conditions

Barclays is acting as sole book running manager and representative of the underwriters for the offering.